[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100614916":3},{"organization":4,"armGroups":7,"interventions":24,"overallOfficials":35,"centralContacts":40,"locations":49,"responsibleParty":75,"collaborators":77,"id":80,"slug":81,"hasResults":82,"nctId":83,"briefTitle":84,"officialTitle":85,"acronym":86,"eligibilityCriteria":87,"healthyVolunteers":88,"sex":89,"minAge":90,"maxAge":91,"enrollmentInfo":92,"targetDuration":30,"studyType":95,"phases":96,"briefSummary":98,"conditions":99,"keywords":30,"overallStatus":66,"whyStopped":30,"lastUpdateSubmitDate":101,"lastUpdatePostDateStruct":102,"startDateStruct":105,"completionDateStruct":107,"leadSponsor":109,"locationsCount":110},{"fullName":5,"class":6},"University of Birmingham","OTHER",[8,15,19],{"label":9,"type":10,"description":11,"interventionNames":12},"pre-meal low dose whey protein","ACTIVE_COMPARATOR","Low whey protein dose administration before meals",[13,14],"Dietary Supplement: Glycaemic control with whey protein","Dietary Supplement: Glycaemic control with different doses of whey protein",{"label":16,"type":10,"description":17,"interventionNames":18},"pre-meal moderate dose whey protein","Moderate whey protein dose administration before meals",[13,14],{"label":20,"type":21,"description":22,"interventionNames":23},"pre-meal protein-free placebo","PLACEBO_COMPARATOR","protein-free placebo administration before meals",[13],[25,31],{"type":26,"name":27,"description":28,"armGroupLabels":29,"otherNames":30},"DIETARY_SUPPLEMENT","Glycaemic control with whey protein","Comparing pre-meal supplementation of whey protein to protein-free placebo.",[9,16,20],null,{"type":26,"name":32,"description":33,"armGroupLabels":34,"otherNames":30},"Glycaemic control with different doses of whey protein","Comparing pre-meal supplementation of moderate whey protein to a low dose of whey protein.",[9,16],[36],{"name":37,"affiliation":38,"role":39},"Leigh Breen, PhD","University of Birmingham and University of Leciester","PRINCIPAL_INVESTIGATOR",[41,46],{"name":37,"role":42,"phone":43,"phoneExt":44,"email":45},"CONTACT","(0)1214144109","+44","l.breen@bham.ac.uk",{"name":47,"role":42,"phone":30,"phoneExt":30,"email":48},"Marie Korzepa, PhD","m.korzepa@bham.ac.uk",[50,64],{"facility":51,"status":52,"city":53,"state":54,"zip":55,"country":56,"countryCode":57,"cosmosGeoPoint":58,"geoPoint":63,"contacts":30},"School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham","ENROLLING_BY_INVITATION","Birmingham","West Midlands","B15 2TT","United Kingdom","UK",{"type":59,"coordinates":60},"Point",[61,62],-1.89983,52.48142,{"lat":62,"lon":61},{"facility":65,"status":66,"city":53,"state":30,"zip":30,"country":56,"countryCode":57,"cosmosGeoPoint":67,"geoPoint":69,"contacts":70},"Heartlands Hospital","RECRUITING",{"type":59,"coordinates":68},[61,62],{"lat":62,"lon":61},[71],{"name":72,"role":42,"phone":73,"phoneExt":74,"email":30},"Srikanth Bellary, MD","4240234","0121",{"type":76,"investigatorFullName":30,"investigatorTitle":30,"investigatorAffiliation":30,"oldNameTitle":30,"oldOrganization":30},"SPONSOR",[78],{"name":79,"class":6},"Newcastle University","100614916","glycaemic-outcomes-with-whey-protein-in-ageing-100614916",false,"NCT07285811","GLycaemic Outcomes With Whey Protein in ageING","Whey Protein Dose-response Effect on Daily Glycaemic Excursions in Very Old Individuals With Type 2 Diabetes","GLOWING","* Male or female\n* 75-90 years old\n* Type 2 Diabetes (confirmed with glycated haemoglobin (HbA1c) \\>6.5% in clinic or in SportExR)\n* Stable body mass (body mass index (BMI) ≤40kg\u002Fm2)\n* Generally healthy, assessed via a General Health Questionnaire (GHQ)\n* Some residual beta-cell activity (confirmed with urine test on induction)\n* Normal or moderately increased albuminuria (needs to be below 300mg\u002Fg)\n* Normal, mildly or moderately decreased glomerular filtration rate (GFR) (needs to be above 45ml\u002Fmin\u002F1.732).\n* Able and willing to attend SportExR a total of 5 times: 1 induction and 2 testing visits and 2 return check-up visits.\n\nExclusion Criteria:\n\n* \\\u003C75 years old and over 90 years of age\n* Currently on fast-acting insulin therapy (i.e., Humalog)\n* Confirmed uncontrolled diabetes (HbA1C \\>10% or 85mmol\u002Fmol).\n* Currently on GLP-1 therapy\n* Habitual smoker or vaper\n* Veganism\n* Lactose or dairy intolerance\n* Coeliac or gluten intolerance\n* History of gastrointestinal disease\n* Experienced a hyperglycaemic or hypoglycaemic event requiring treatment in the past 12 months\n* Recent Ischemic stroke (\\\u003C3 months).\n* Use of anticoagulants (e.g. warfarin, rivaroxaban)\n* Considered unwilling or unable to comply with the study protocol requirements by the research team",true,"ALL","75 Years","90 Years",{"count":93,"type":94},32,"ESTIMATED","INTERVENTIONAL",[97],"NA","The goal of this placebo-controlled, partial crossover design study is to identify the impact of consuming whey protein before meals on free-living glucose control in older adults living with type 2 diabetes.\n\nThe primary specific objective is to determine the effect of a thrice daily whey protein pre-meal supplementation at two doses, on glucose excursions over a 7-day free-living period in adults aged 75-90 years of age, living with type 2 diabetes, compared with a non-protein placebo.\n\nParticipants will consume the whey protein and placebo for 7 days each, before each meal. All participants will consume the placebo and one of two doses of whey protein, in a randomised order.",[100],"Type 2 Diabetes","2025-12-02",{"date":103,"type":104},"2025-12-16","ACTUAL",{"date":106,"type":94},"2025-12",{"date":108,"type":94},"2026-12",{"name":5,"class":6},2]